Shinji Uemoto

A new technique for intraoperative continuous biliary drainage during pancreatoduodenectomy.

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation.

Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice.

Assessment of cardiac output in liver transplantation recipients.

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.

Liver retransplantation with external biliary diversion for progressive familial intrahepatic cholestasis type 1: a case report.

Recent evidence in the treatment of small hepatocellular carcinoma.

Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.

Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

Spontaneous necrosis of solid gallbladder adenocarcinoma accompanied with pancreaticobiliary maljunction.

Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bile.

Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma.

Successful stent placement for hepatic venous outflow obstruction in pediatric living donor liver transplantation, including a case series review.

Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.

Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome.

Value of FOXP3 expression in peripheral blood as rejection marker after miniature swine lung transplantation.

Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis.

Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.

Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

Quality assessment of randomized controlled trials involving liver surgery.

The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.

Two different methods for donor hepatic transection: cavitron ultrasonic surgical aspirator with bipolar cautery versus cavitron ultrasonic surgical aspirator with radiofrequency coagulator-A randomized controlled trial.

Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case.

Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.

Prognostic value of metastin expression in human pancreatic cancer.

Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation.

Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation.

The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation.

Prophylactic respiratory management after liver resection with bilevel positive airway pressure ventilation: Report of three cases.

MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients.

Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience.

Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.

The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation.

A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.

Transperitoneal laparoscopic surgery using endostaplers for adult unilateral diaphragmatic eventration.

Significance of portal venous VEGF during liver regeneration after hepatectomy.

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.

Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.

Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.

Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.

Establishment of a cell line derived from a mouse fetal liver that has the characteristic to promote the hepatic maturation of mouse embryonic stem cells by a coculture method.

Unusual biliary collaterals inside a transplanted liver.

The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.

Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation.

Tumescent local anesthesia in inguinal herniorrhaphy with a PROLENE hernia system: original technique and results.

Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver.

Living-related liver transplantation in patients with variceal bleeding: outcome and prognostic factors.

Selection criteria for patients with hepatocellular carcinoma in liver transplantation.

Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT.

Liver transplantation for hepatocellular carcinoma: the Kyoto experience.

Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation.

Percutaneously adjustable portal vein banding device could prevent post-operative liver failure--artificial control of portal venous flow is the key to a new therapeutic world.

Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation.

Is biliary bile acid a good predictor for acute cellular rejection in living donor liver transplantation?

FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.

In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center.

Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.

Reconstruction of hepatic veins by anastomosis with suprahepatic IVC in the posterior mediastinum in living donor liver transplantation for Budd-Chiari syndrome.

Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver.

Acute renal failure after high-dose methotrexate therapy in a patient with ileostomy.

In vitro hepatic maturation of human embryonic stem cells by using a mesenchymal cell line derived from murine fetal livers.

Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait?

[Current status of liver transplantation for liver cirrhosis and unsolved problem].

Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?

Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.

Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.

Pediatric orthotopic living-donor liver transplantation cures pulmonary hypertension caused by Abernethy malformation type Ib.

Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.

[Recent advances and future prospects in research of small bowel transplantation].

Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases.

Surgery-related morbidity in living donors for liver transplantation.

A Phosphodiesterase III Inhibitor Protects Rat Liver From Sinusoidal Obstruction Syndrome Through Heme Oxygenase-1 Induction.

Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.

Use of rat segmental intestine for fetal pancreatic transplantation.

Development of a portocaval shunt using a small intestinal segment in rats.

Can children catch up in growth after living donor liver transplantation?

Usefulness of the Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma.

The rare insertion of b4 with trifurcated portal vein in live donor.

Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan.

Chemopreventive anti-cancer agent acyclic retinoid suppresses allogeneic immune responses in rats.

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.

Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.

Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before.

Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide.

Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients.

Genetic lineage tracing, a powerful tool to investigate the embryonic organogenesis and adult organ maintenance of the pancreas.

Identification of serum proteins that bind with S100A8, S100A9 and S100A8/A9: clinical significance of using proteins for monitoring the postoperative condition of liver recipients.

Xanthogranulomatous cholecystitis complicated with primary sclerosing cholangitis: report of a case.

Effects of neutrophil elastase inhibitor on progression of acute lung injury after liver transplantation.

Noninvasive ventilation improves the outcome of pulmonary complications after liver resection.

Successful left hemihepatectomy and perioperative management of a patient with biliary cystadenocarcinoma, complicated with MELAS syndrome: report of a case.

Islet transplantation using donors after cardiac death: report of the Japan Islet Transplantation Registry.

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.

Does living donation have advantages over deceased donation in liver transplantation?

Molecular and clinical analysis of Japanese patients with persistent congenital hyperinsulinism: predominance of paternally inherited monoallelic mutations in the KATP channel genes.

Comparison between psychosocial long-term outcomes of recipients and donors after adult-to-adult living donor liver transplantation.

Liver transplantation for congenital biliary dilatation: a single-center experience.

Optimal tissue tension for secure laparoscopic knots.

The generation of donor-specific CD4+CD25++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation.

FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model.

A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers.

Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency.

Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine.

Posttransplant bacteremia in adult living donor liver transplant recipients.

Living-donor liver transplantation for progressive familial intrahepatic cholestasis.

Progressive familial intrahepatic cholestasis.

Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan.

The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas.

[Liver transplantation].

Noninvasive intraductal papillary mucinous neoplasm with para-aortic lymph node metastasis: report of a case.

Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis.

Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model.

Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma.

Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation.

MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria.

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.

Management of ABO-incompatible living-donor liver transplantation: past and present trends.

[Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy].

Improved preservation and microcirculation with POLYSOL after partial liver transplantation in rats.

Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence?

Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: report of a case.

Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation.

Impact of pretransplant nutritional status in patients undergoing liver transplantation.

Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation.

Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels.

Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: a variety of functional roles of the two proteins as regulators in acute inflammatory reaction.

Luminescence technology in preservation and transplantation for rat islet.

Augmented damage of islets by impaired exocrine acinar cells undergoing apoptosis that is possibly converted to necrosis during isolation.

Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.

Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model.

Three-dimensional ex vivo imaging and analysis of intraportal islet transplants.

Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics.

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells.

Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience.

[Molecular pathogenesis of hepatocellular carcinoma].

Liver transplantation for severe hepatitis in patients with common variable immunodeficiency.

Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.

[Role of JSS in education for young surgeons].

Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection.

Left-sided grafts for living-donor liver transplantation and split grafts for deceased-donor liver transplantation: their impact on long-term survival.

Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation.

Impact of venous systemic oxygen persufflation supplemented with nitric oxide gas on cold-stored, warm ischemia-damaged experimental liver grafts.

A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan.

Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case.

Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.

Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match.

Fulminant liver failure models with subsequent encephalopathy in the mouse.

Beneficial effects of continuous positive airway pressure therapy in a pediatric intestinal transplant recipient with obstructive sleep apnea.

Delayed gastric emptying improved by straight stomach reconstruction with twisted anastomosis to the jejunum after pylorus-preserving pancreaticoduodenectomy (PPPD) in 118 consecutive patients at a single institution.

Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma.

Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients.

Standard hepatic vein reconstruction with patch plasty using the native portal vein in adult living donor liver transplantation.

Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin Eâ‚‚ receptor subtype 4 agonist.

Attenuation of murine graft-versus-host disease by a tea polyphenol.

Successful living donor liver transplantation for fulminant hepatic failure that manifested immediately after cesarean delivery.

Effects of post-transplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation.

Invariant natural killer T cells infiltrate intestinal allografts undergoing acute cellular rejection.

Use of recipient's left colic artery for arterial reconstruction during liver transplantation in Alagille syndrome with vasculopathy: a case report.

Hepatic arterial reconstruction with a short-term patency by using micro T-tube in rat liver transplantation.

Comparative study of transplantation of hepatocytes at various differentiation stages into mice with lethal liver damage.

Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.

Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal.

Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation.

Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat.

Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.

Effect of specific activation of γ-aminobutyric acid receptor in vivo on oxidative stress-induced damage after extended hepatectomy.

Hepatic arterial reconstruction for orthotopic liver transplantation in the rat.

An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records.

The Role of Liver Transplantation for Congenital Extrahepatic Portosystemic Shunt.

Matrix metalloproteinase-9 contributes to parenchymal hemorrhage and necrosis in the remnant liver after extended hepatectomy in mice.

How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results.

Transplantation of Engineered Chimeric Liver With Autologous Hepatocytes and Xenobiotic Scaffold.

Use of noninvasive ventilation for pediatric patients after liver transplantation: Decrease in the need for reintubation.

Endovascular management of early hepatic artery thrombosis after living donor liver transplantation.

Simple and reproducible hepatectomy in the mouse using the clip technique.

Pre transplant serum magnesium level predicts outcome after pediatric living donor liver transplantation.

Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts.

Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.

Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells.

Long-term quality of life of donors after living donor liver transplantation.

GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function.

Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.

An adult with primary hyperoxaluria type 1 regrets not receiving preemptive liver transplantation during childhood: report of a case.

Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification.

Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population.

Liver graft pretreated in vivo or ex vivo by γ-aminobutyric acid receptor regulation.

Histology of Intestinal Allografts: Lymphocyte Apoptosis and Phagocytosis of Lymphocytic Apoptotic Bodies Are Diagnostic Findings of Acute Rejection in Addition to Crypt Apoptosis.

Pre- and perioperative factors affecting infection after living donor liver transplantation.

Living donor liver transplantation for hepatitis C.

[Regenerative medicine by regenerating islets: present and future therapies for diabetes].

Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan.

Clinical impact of PET/CT on the management of patients with intrahepatic cholangiocarcinoma.

Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures.

Liver Transplantation for Primary Hyperoxaluria Type 1: A Single-center Experience during Two Decades in Japan.

Intragraft Vδ1 γδ T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance.

Small-for-size syndrome in living donor liver transplantation.

Effect of olprinone on liver microstructure in rat partial liver transplantation.

Impact of venous-systemic oxygen persufflation with nitric oxide gas on steatotic grafts after partial orthotopic liver transplantation in rats.

Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.

Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome.

Endoscopic stent placement above the intact sphincter of Oddi for biliary strictures after living donor liver transplantation.